novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide Lilly says weight loss drug cuts heart failure by 38% in trial ESC25: Novo's Wegovy slashes CV

Gq-mER is present in the hypothalamus and its expression is restricted to NPY/AgRP neurons where it decreases neuronal activity (82, 83, 92)

When two or more doses of the medication are skipped, a person can lose tolerance, increasing the risk of severe side effects once the GLP-1 receptor agonist is resumed

Always verify the beyond-use date with your dispensing pharmacy and check your vial before every injection

and Pulmonary aspiration while under anesthesia or during surgery Wernickes Encephalopathy Drugmakers Eli Lilly and Novo Nordisk may be facing numerous lawsuits filed by people who used the medications and experienced serious complications or required hospitalization

10.1111/cts.12833 13 HanS

See our full semaglutide versus tirzepatide comparison for additional context on the incretin therapy landscape